Traws Pharma, Inc. (TRAW) NASDAQ
2.14
-0.04(-1.83%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.14
-0.04(-1.83%)
Currency In USD
| Market Cap | 13.79M |
| Enterprise Value | -7.55M |
| P/E Ratio | -1.37 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 3.66 |
| Price/Book Ratio | 1.51 |
| Enterprise/Revenue | -1.03 |
| Enterprise/EBITDA | 0.26 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
| Profit Margin | -3.26 |
| Operating Margin | -3.51 |
| Return On Assets | -0.58 |
| Return On Equity | 0.78 |
| Revenue | 226,000 |
| Revenue/Share | 0.48 |
| Gross Profit | 214,000 |
| EBITDA | -166.51M |
| Net Income | -54.67M |
| Diluted EPS | -35.21 |
| Total Cash | 13.08M |
| Total Cash/Share | 2.25 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.09 |
| Book Value Per Share | 1.42 |
| 52-Week Change | -24.65 |
| 52-Week High | 3.27 |
| 52-Week Low | 0.97 |
| Moving Average 50 Days | 1.92 |
| Moving Average 200 Days | 1.88 |
| Average Volume | 203,473 |
| Shares Outstanding | 4.77M |
| % Held by Institutions | 58.73 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | September 23, 2024 |